Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and pre|CISION tumor-targeted chemotherapy. The company operates in the United Kingdom, Rest of Europe, Asia, and North America.Avacta Group PLC is a United Kingdom based company, which caters to the healthcare sector. It develops medical diagnostic products such as reagents and arrays which are helpful in drug discovery.